RNA, the ability of the RNA-protein complex to reach its destination was impaired.
She2p binds to its target RNAs in the nucleus, but She3p was thought to be a cytoplasmic protein. To test that belief, they examined its distribution in a cell with a temperature-sensitive defect in nuclear export, and saw that even at high temperatures, when nuclear export was shut down, She3p was found only in the cytoplasm, indicating that it, unlike She2p, waits for the nascent transport complex to enter the cytoplasm before it binds on.
Based on their results, the authors propose a two-step model of transport complex formation. Within the nucleus, She2p binds to the mRNA as it is transcribed, and then shuttles it to the cytoplasm. She2p binds loosely and promiscuously, though, catching up mRNAs both with and without zipcodes. Once in the cytoplasm, She3p joins on, tightening the grip on mRNAs that contain zipcodes while booting out those without them. With the myosin motor attached to She3p, the complex motors off to its destination elsewhere in the cell.
The results in this study indicate that quality control in mRNA transport relies on a reciprocal action: the complex proteins together ensure that only those Selected PLoS Biology research articles are accompanied by a synopsis written for a general audience to provide non-experts with insight into the significance of the published work. mRNAs with a destination tag are incorporated into the transport complex, and the mRNA, by binding to each of the proteins in the complex, ensures that all are on board before the journey starts.
These findings are an important step forward to understand how mRNAs are transported to their chosen destination in yeast, and opens up the possibility that a similar strategy is followed in other organisms.
